Continuous blood glucose monitoring devices:Diabetes Care Devices Market
The Global Diabetes Care Devices Market will grow at a CAGR of 5.3% from 2017 to 2022 to reach USD 26,710.3 million by 2022,according to the latest publication from Meticulous Research®
Diabetes is a chronic metabolic disorder resulting from
defects of insulin secretion and/or action. Type 1 diabetes (T1D) is
characterized by a lack of insulin secretion by the pancreas and can be treated
by exogenous administration of insulin, while Type 2 diabetes (T2D) whose onset
is often facilitated by bad daily habits, e.g., physical inactivity and
unhealthy diet, is characterized by an inefficiency in the action of insulin.
According to the World Health Organization, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014, which means that about 8.5% of adults aged 18 years and older had diabetes, with the prospective of exceeding 500 million cases in 2030.
Request Sample Report:https://www.meticulousresearch.com/request-sample-report/?cp_id=3438
Intensive control of blood glucose in the diabetes
management requires accurate determination of blood glucose concentrations and
needs application of state-of-the-art technology. Until very recently, this
determination could only be achieved by the attainment of multiple capillary
blood glucose determinations each day, a practice that is cumbersome,
inconvenient, expensive, and a significant disincentive to achieving target
blood glucose goals. Even when applied conscientiously, self-monitoring of
blood glucose (SMBG) provides only a snapshot blood glucose concentration
without providing any information about the direction or rate of blood glucose
change. As a result, many patients are unable to achieve blood glucose targets
despite testing their blood glucose multiple times daily.
The conventional technique of blood glucose monitoring has
been replaced by the advent of continuous glucose monitoring systems. These
devices come with a novel technology, allowing quick and easy detection of
blood glucose levels in the tissue fluid deploying a small sensor for
inspection. By continuously observing readings at regular intervals, the
continuous glucose monitoring systems allow patients to take adequate measures
before hyperglycemic or hypoglycemic levels are reached.
According to the National Institute of Health, overall
measurement error has been reduced by twofold and accuracy continues to improve
with the introduction of continuous glucose monitoring devices.
The CGM
represents a significant advancement because it provides real-time information
about current blood glucose, provides short-term feedback about the
effectiveness of diabetes interventions and warnings when blood glucose
concentrations become dangerously high or low.
Modern commercial CGM sensors can transfer data directly to
smartphones, which act as a substitute for traditional CGM receivers. The
availability of smartphone- and internet-connected CGM sensors together with
the extension of their use to a larger population will allow the creation of
large databases in which CGM data are integrated with different data sources.
For example, CGM data can be merged with information provided by other medical
devices (e.g., SMBG monitors, insulin pumps, and insulin pens) and mHealth apps
used in diabetes management. In addition, the connection of CGM to smartphones
equipped with GPS connectivity allows the geo-referencing of data collected by
these devices. This will provide information on the context of CGM measurement,
potentially driving to a better understanding of diabetes and the environmental
factors that can influence its onset/course.
Thus, rising prevalence of diabetes across the world increases
the need for sophisticated and reliable devices and technologies for rapid
detection of blood glucose level. Thus, owing to the unique properties and
increasing adoption in developing countries along with the focus on
self-management of the disease, continuous glucose monitoring devices have been
witnessing a rapid growth in the global market, which is expected to grow at a
CAGR of 8.3% to reach USD 1,750.0 million by 2022, according to the Meticulous
Research™.
Download Sample Report: https://www.meticulousresearch.com/download-sample-report/?cp_id=3438
Contact
Us:
Viren Shrivastava
AVP-
Global Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Email:
viren@meticulousresearch.com
Comments
Post a Comment